PBPK modeling of short-term (0 to 5 min) human inhalation exposures to halogenated hydrocarbons

Inhalation Toxicology

Volumn 10, Issue 5, 1998, Pages 411-429

  Vinegar, A ^a   Jepson, G W ^a,b   Overton, J H ^c  

^a ALION SCIENCE AND TECHNOLOGY   (United States)

^b AIR FORCE RESEARCH LABORATORY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0031840654     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/089583798197600     Document Type: Article

References (15)

1. Crapo, J. D., Young, S. L., Fram, E. K., Pinkerton, K. E., Barry, B. E., and Crapo, R. O. 1983. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am. Rev. Respir. Dis. 128:S42-S46.
2. Dankovic, D. A., and Bailer, A. J. 1993. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model. Fundam. Appl. Toxicol. 22:20-25.
3. Eger, E. I. II. 1990. Uptake and distribution. In Anesthesia, 3rd ed., ed. R. D. Miller, pp. 85-104. New York: Churchill Livingstone.
4. Holaday, D. A. 1977. Absorption, biotransformation, and storage of halothane. Environ. Health Perspect. 21:165-169.
5. Holaday, D. A., Fiserova-Bergerova, V., Latto, I. P., and Zumbiel, M. A. 1975. Resistance of isoflurane to biotransformation in man. Anesthesiology 43:325-332.
6. Jarabek, A. M., Fisher, J. W., Rubenstein, R., Lipscomb, J. C., Williams, R. J., Vinegar, A., and McDougal, J. N. 1994. Mechanistic insights aid the search for CFC substitutes: Risk assessment of HCFC-123 as an example. Risk Anal. 14:231-250.
7. Lerman, Y., Winkler, E., Tirosh, M. S., Danon, Y., and Almog, S. 1991. Fatal accidental inhalation of bromochlorodifluoromethane (Halon 1211). Hum. Exp. Toxicol. 10:125-128.
8. Lerou, J. G. C., Dirksen, R., Beneken Kolmer, H. H., and Booij, L. H. D. J. 1991. A system model for closed-circuit inhalation anesthesia I. Computer study. Anesthesiology 75:345-355.
9. Overton, J. H., and Graham, R. C. 1993. The role of the respiratory tract in the uptake of inhaled gases and vapors. Toxicologist 13(1):260.
10. Sutton, T. S., Koblin, D. D., Gruenke, L. D., Weiskopf, R. B., Rampil, I. J., Waskell, L., and Eger, E. I. II. 1991. Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth. Analg. 73:180-185.
11. U.S. Environmental Protection Agency. 1994. SNAP Technical Background Document: Risk Screen on the Use of Substitutes for Class I Ozone-Depleting Substances, Fire Suppression and Explosion Protection (Halon Substitutes). Washington, DC: U.S. Environmental Protection Agency, Office of Air and Radiation, Stratospheric Protection Division.
12. Vinegar, A., and Jepson, G. W. 1996. Cardiac sensitization thresholds of Halon replacement chemicals predicted in humans by physiologically based pharmacokinetic modeling. Risk Anal. 16(4): 571-579.
13. Vinegar, A., Williams, R. J., Fisher, J. W., and McDougal, J. N. 1994. Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: A physiologically based pharmacokinetic model in the male Fischer 344 rat. Toxicol. Appl. Pharmacol. 129:103-113.
14. Williams, R. J., Vinegar, A., McDougal, J. N., Jarabek, A. M., and Fisher, J. W. 1996. Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: A corollary approach to physiologically based pharmacokinetic modeling. Fundam. Appl. Toxicol. 30:55-66.
15. Yasuda, N., Lockhart, S. H., Eger, E. I. II, Johnson, B. H., Freire, B. A., and Fassoulaki, A. 1991. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 74:489-498.